The menopause transition is, statistically, a universal experience for women who live long enough to reach it. It affects sleep, cognition, mood, cardiovascular risk, bone density, and dozens of other aspects of health and wellbeing. And yet the average primary care physician in the United States receives less than two hours of menopause education in medical school.
Amy Harrison’s experience — two years of worsening symptoms, repeated medical encounters that failed to identify the cause, and a long fight to be taken seriously — is the direct product of that educational gap.
Two Years of Not Knowing
“My life turned upside down,” Amy says. “I wasn’t sleeping. I was anxious in ways I had never been before. I felt like I was losing my mind. And nobody could tell me why.”
Her symptoms began in her late 40s: disrupted sleep, cognitive changes she describes as “brain fog,” joint pain, mood instability, and hot flashes that she had not yet connected to menopause. She saw her primary care physician. She saw a psychiatrist. She had blood work done. The results came back “normal.” She was offered antidepressants.
“Nobody asked about my cycle. Nobody mentioned perimenopause. I had to bring it up myself, and even then, I wasn’t taken seriously immediately.”
Fighting to Be Heard
“It took time, but my general practitioner also listened to me when I consistently had to push and advocate for myself,” she recalls. “It has been a heartbreaking two years, as my life has turned upside down and I am surprised I kept fighting and still do.”
What Amy found, when she eventually found providers who understood menopause, was that hormone therapy significantly improved her quality of life. This is the evidence-based outcome for many women with vasomotor and related symptoms — yet the treatment she needed had been decades of stigma away from being offered.
The Broader Failure
Amy’s two-year diagnostic odyssey is not an outlier. Surveys of menopausal women consistently document delayed diagnosis, inadequate symptom management, and clinical encounters in which symptoms were attributed to depression, anxiety, or the inevitable difficulties of aging rather than to a biological transition that has well-characterized, treatable manifestations.
The chilling effect of the 2002 Women’s Health Initiative findings on hormone therapy prescribing has persisted long past the evidence that drove the original concern. Women are not being offered treatments that work because clinicians are not being trained to offer them.
What She Wants the System to Know
“I shouldn’t have had to fight this hard. A woman in her late 40s, presenting with the exact symptom profile I had, should have had menopause on the differential from the first appointment. That is a training problem. And training problems have solutions.”
She is right. They do.
Amy Harrison shared her experience with the Society for Women’s Health Research as part of their Women’s Health Perspectives series.